These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 30288682)

  • 1. Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings.
    Koshimichi H; Ishibashi T; Kawaguchi N; Sato C; Kawasaki A; Wajima T
    Clin Drug Investig; 2018 Dec; 38(12):1189-1196. PubMed ID: 30288682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza.
    Koshimichi H; Tsuda Y; Ishibashi T; Wajima T
    J Pharm Sci; 2019 May; 108(5):1896-1904. PubMed ID: 30557562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics of Baloxavir Marboxil in Japanese Pediatric Influenza Patients.
    Koshimichi H; Ishibashi T; Wajima T
    J Pharm Sci; 2019 Sep; 108(9):3112-3117. PubMed ID: 30998942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
    N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza.
    Yang T
    Ann Pharmacother; 2019 Jul; 53(7):754-759. PubMed ID: 30674196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.
    Watanabe A; Ishida T; Hirotsu N; Kawaguchi K; Ishibashi T; Shishido T; Sato C; Portsmouth S; Tsuchiya K; Uehara T
    Antiviral Res; 2019 Mar; 163():75-81. PubMed ID: 30684563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baloxavir: First Global Approval.
    Heo YA
    Drugs; 2018 Apr; 78(6):693-697. PubMed ID: 29623652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.
    Taieb V; Ikeoka H; Ma FF; Borkowska K; Aballéa S; Tone K; Hirotsu N
    Curr Med Res Opin; 2019 Aug; 35(8):1355-1364. PubMed ID: 30810054
    [No Abstract]   [Full Text] [Related]  

  • 9. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
    Ikematsu H; Hayden FG; Kawaguchi K; Kinoshita M; de Jong MD; Lee N; Takashima S; Noshi T; Tsuchiya K; Uehara T
    N Engl J Med; 2020 Jul; 383(4):309-320. PubMed ID: 32640124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.
    Li Y; Wang X; Liao Y; Zeng Y; Lin W; Zhuang W
    BMC Infect Dis; 2024 May; 24(1):446. PubMed ID: 38724914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute ischemic colitis with hematochezia related to baloxavir marboxil treatment for influenza A.
    Kanai N; Hashimoto T; Fukuda M; Shijyo T
    J Infect Chemother; 2019 Dec; 25(12):1040-1042. PubMed ID: 31176533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 13. Baloxavir marboxil, Fremanezumab-vfrm, Galcanezumab-gnlm, and Lofexidine hydrochloride.
    Hussar DA; Moyer MR
    J Am Pharm Assoc (2003); 2019; 59(1):141-144. PubMed ID: 30580925
    [No Abstract]   [Full Text] [Related]  

  • 14. Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenza.
    Locke SC; Splawn LM; Cho JC
    Drugs Today (Barc); 2019 Jun; 55(6):359-366. PubMed ID: 31250840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
    Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
    Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.
    Fukao K; Noshi T; Yamamoto A; Kitano M; Ando Y; Noda T; Baba K; Matsumoto K; Higuchi N; Ikeda M; Shishido T; Naito A
    J Antimicrob Chemother; 2019 Mar; 74(3):654-662. PubMed ID: 30476172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects.
    Kawaguchi N; Koshimichi H; Ishibashi T; Wajima T
    Clin Drug Investig; 2018 Nov; 38(11):1053-1060. PubMed ID: 30203386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects.
    Kim Y; Lee S; Kim Y; Jang IJ; Lee S
    Clin Transl Sci; 2022 Feb; 15(2):422-432. PubMed ID: 34664769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection.
    Ando Y; Noshi T; Sato K; Ishibashi T; Yoshida Y; Hasegawa T; Onishi M; Kitano M; Oka R; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    J Antimicrob Chemother; 2021 Jan; 76(1):189-198. PubMed ID: 33035324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baloxavir heralds a new era in influenza virus biology.
    Kikuchi T; Watanabe A
    Respir Investig; 2019 Jan; 57(1):1-2. PubMed ID: 30396860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.